89 related articles for article (PubMed ID: 3952515)
21. Prednimustine in refractory non-Hodgkin's lymphoma: a phase II study of the Northern California Oncology Group.
Gandara DR; Wold HG; Redmond J; Kohler M; Reynolds R; Wong P; Forsythe J; Fisher K; Lewis B
Semin Oncol; 1986 Mar; 13(1 Suppl 1):14-8. PubMed ID: 3952517
[TBL] [Abstract][Full Text] [Related]
22. Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancer.
Rankin EM; Harvey C; Knight RK; Rubens RD
Cancer Treat Rep; 1987 Nov; 71(11):1107-8. PubMed ID: 3119205
[No Abstract] [Full Text] [Related]
23. Prednimustine in advanced soft tissue sarcomas.
Karakousis CP; Didolkar MS; Ambrus JL; Holyoke ED
Cancer Treat Rep; 1982 Jan; 66(1):201-2. PubMed ID: 7053259
[No Abstract] [Full Text] [Related]
24. On the clinical pharmacology of prednimustine.
Plym Forshell G; Gunnarsson PO; Liljekvist J
Br J Clin Pharmacol; 1983 Dec; 16(6):760-1. PubMed ID: 6661369
[No Abstract] [Full Text] [Related]
25. Phase II trial of prednimustine in children with recurrent cancer: a Children's Cancer Study Group report.
Gaynon PS; Baum ES; Krivit W; Hammond D
Cancer Treat Rep; 1982 Jul; 66(7):1583-4. PubMed ID: 6284362
[No Abstract] [Full Text] [Related]
26. [Clinical experiences in tumor-oriented anti-cancer drugs].
Ohsawa N
Nihon Naika Gakkai Zasshi; 1988 Mar; 77(3):313-7. PubMed ID: 2841390
[No Abstract] [Full Text] [Related]
27. Prednimustine treatment in malignant lymphomas.
Szántó I; Fleischmann T; Eckhardt S
Oncology; 1989; 46(4):205-7. PubMed ID: 2662086
[TBL] [Abstract][Full Text] [Related]
28. [Angioimmunoblastic lymphadenopathy. Remission obtained with prednimustine after failure of corticosteroid therapy and cyclophosphamide].
Donadio D; Navarro M; Izarn P; Clot J; Emberger JM
Nouv Presse Med; 1980 Jan; 9(3):188-9. PubMed ID: 7355106
[No Abstract] [Full Text] [Related]
29. [Acute monoblastic leukemia in non-Hodgkin's malignant lymphoma treated with prednimustine].
Mahe M; Raffi F; Grolleau JY; Baudot S
Therapie; 1989; 44(5):378-9. PubMed ID: 2814920
[No Abstract] [Full Text] [Related]
30. Prednimustine in acute nonlymphocytic leukemia.
Ayulo MA; Preisler HD
Am J Clin Oncol; 1983 Apr; 6(2):207-9. PubMed ID: 6829495
[No Abstract] [Full Text] [Related]
31. Estimation of chlorambucil, phenyl acetic mustard and prednimustine in human plasma by high-performance liquid chromatography.
Newell DR; Hart LI; Harrap KR
J Chromatogr; 1979 Sep; 164(1):114-9. PubMed ID: 541393
[No Abstract] [Full Text] [Related]
32. A randomized comparative study of prednimustine and doxorubicin in patients with metastatic breast cancer.
Allegra JC
Semin Oncol; 1986 Mar; 13(1 Suppl 1):42-4. PubMed ID: 3513319
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxicity and metabolism of prednimustine, chlorambucil and prednisolone in a Chinese hamster cell line.
Hartley-Asp B; Gunnarsson PO; Liljekvist J
Cancer Chemother Pharmacol; 1986; 16(2):85-90. PubMed ID: 3948307
[TBL] [Abstract][Full Text] [Related]
34. Prednisolone plasma levels after oral administration of Prednimustine. Comparison with levels obtained after administration of an equimolar dose of prednisolone.
Sayed A; Hove WV; Vermeulen A
Oncology; 1981; 38(6):351-5. PubMed ID: 7301281
[TBL] [Abstract][Full Text] [Related]
35. Treatment of refractory chronic lymphocytic leukemia with prednimustine: a phase II study using strict response criteria.
Gandara DR; George CB; Ries CA; Koretz MM; Lewis JP
Cancer Chemother Pharmacol; 1987; 19(2):165-8. PubMed ID: 3568275
[TBL] [Abstract][Full Text] [Related]
36. Prednimustine in combination with methotrexate and 5-FU (PMF): a pilot study.
Boesen E; Mouridsen HT
Cancer Treat Rep; 1982 Dec; 66(12):2081-3. PubMed ID: 7139649
[TBL] [Abstract][Full Text] [Related]
37. Disposition of orally administered 14C-prednimustine in cancer patients.
Gaver RC; Deeb G; Pittman KA; Issell BF; Mittelman A; Smyth RD
Cancer Chemother Pharmacol; 1983; 11(3):139-43. PubMed ID: 6640823
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the cytotoxic effect of prednimustine in cultured cells with high or low levels of metallothionein.
Endresen L
Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):49-57. PubMed ID: 6702467
[TBL] [Abstract][Full Text] [Related]
39. Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assay.
Oppitz MM; Musch E; Malek M; Rüb HP; von Unruh GE; Loos U; Mühlenbruch B
Cancer Chemother Pharmacol; 1989; 23(4):208-12. PubMed ID: 2924378
[TBL] [Abstract][Full Text] [Related]
40. Comparative carcinogenic activity of prednimustine, chlorambucil, prednisolone and chlorambucil plus prednisolone in Sprague-Dawley rats.
Berger MR; Habs M; Schmähl D
Arch Geschwulstforsch; 1985; 55(6):429-42. PubMed ID: 4083998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
